Literature DB >> 21930108

Iron oxide nanoparticles for targeted cancer imaging and diagnostics.

Joshua E Rosen1, Lorena Chan, Dar-Bin Shieh, Frank X Gu.   

Abstract

Superparamagnetic iron oxide nanoparticles (SPIONs) have proven to be highly effective contrast agents for the magnetic resonance imaging diagnosis of solid tumors. This review examines the various techniques that are available to selectively target SPIONs toward a wide variety of cancerous tissues, with specific attention given to how the surface properties imparted by various targeting ligands affect the particles tissue distribution and pharmacokinetics. An in-depth examination of the various human cell lines utilized to test the assorted targeting methods is also presented, as well as an overview of the various types of cancer against which each targeting method has been utilized for both in vivo and in vitro studies. From the Clinical Editor: Functionalized superparamagnetic iron oxide nanoparticles (SPIONs) are very potent negative contrast materials for magnetic resonance imaging-based diagnosis. This comprehensive review examines techniques that selectively target SPIONs toward a wide variety of malignancies. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21930108     DOI: 10.1016/j.nano.2011.08.017

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  62 in total

1.  Quantification of endocytosis using a folate functionalized silica hollow nanoshell platform.

Authors:  Sergio Sandoval; Natalie Mendez; Jesus G Alfaro; Jian Yang; Sharraya Aschemeyer; Alex Liberman; William C Trogler; Andrew C Kummel
Journal:  J Biomed Opt       Date:  2015-08       Impact factor: 3.170

2.  Simultaneous quantitative susceptibility mapping (QSM) and R2* for high iron concentration quantification with 3D ultrashort echo time sequences: An echo dependence study.

Authors:  Xing Lu; Yajun Ma; Eric Y Chang; Qun He; Adam Searleman; Annette von Drygalski; Jiang Du
Journal:  Magn Reson Med       Date:  2018-01-04       Impact factor: 4.668

3.  Size-dependent ferrohydrodynamic relaxometry of magnetic particle imaging tracers in different environments.

Authors:  Hamed Arami; R M Ferguson; Amit P Khandhar; Kannan M Krishnan
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

4.  A targeted approach to cancer imaging and therapy.

Authors:  Chun Li
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

5.  DNA Aptamer Technology for Personalized Medicine.

Authors:  Hang Xing; Kevin Hwang; Ji Li; Seyed-Fakhreddin Torabi; Yi Lu
Journal:  Curr Opin Chem Eng       Date:  2014-05-01       Impact factor: 5.163

6.  Evaluation of zinc-doped magnetite nanoparticle toxicity in the liver and kidney of mice after sub-chronic intragastric administration.

Authors:  Shanshan Zhu; Xiaolong Xu; Rui Rong; Bing Li; Xue Wang
Journal:  Toxicol Res (Camb)       Date:  2015-11-18       Impact factor: 3.524

Review 7.  Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications.

Authors:  Raziye Mohammadpour; Marina A Dobrovolskaia; Darwin L Cheney; Khaled F Greish; Hamidreza Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2019-07-08       Impact factor: 15.470

8.  Dual-responsive polymer-coated iron oxide nanoparticles for drug delivery and imaging applications.

Authors:  Varsha Sundaresan; Jyothi U Menon; Maham Rahimi; Kytai T Nguyen; Aniket S Wadajkar
Journal:  Int J Pharm       Date:  2014-03-05       Impact factor: 5.875

Review 9.  In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.

Authors:  Hamed Arami; Amit Khandhar; Denny Liggitt; Kannan M Krishnan
Journal:  Chem Soc Rev       Date:  2015-09-21       Impact factor: 54.564

10.  Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances.

Authors:  Richard A Revia; Miqin Zhang
Journal:  Mater Today (Kidlington)       Date:  2016-04       Impact factor: 31.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.